Press Releases Optiva Inc. Reports Third Quarter 2023 Financial Results November 8, 2023 Share FacebookTwitterPinterestWhatsApp Must read Nvidia CEO aiming to set up base in Vietnam, Reuters reports December 10, 2023 Utz Brands to host investor day December 10, 2023 Updated Odronextamab Data from Relapsed/Refractory Diffuse Large B-cell Lymphoma Pivotal Trial Showed Deep and Durable Responses and the Potential of ctDNA To Predict Long-term... December 10, 2023 Jasper Therapeutics Presents Positive Final Results from Phase 1 Study of Briquilimab in Patients with AML or MDS Undergoing Hematopoietic Cell Transplant in Oral... December 10, 2023 Optiva Inc. Reports Third Quarter 2023 Financial Results Source link Share FacebookTwitterPinterestWhatsApp Previous articleDINARCOIN ICO (DNC): A Golden Revolution in Digital CurrencyNext articleMeta Plus Token ICO (MTS): Digital Currencies for Daily Life More articles Updated Odronextamab Data from Relapsed/Refractory Diffuse Large B-cell Lymphoma Pivotal Trial Showed Deep and Durable Responses and the Potential of ctDNA To Predict Long-term... December 10, 2023 Jasper Therapeutics Presents Positive Final Results from Phase 1 Study of Briquilimab in Patients with AML or MDS Undergoing Hematopoietic Cell Transplant in Oral... December 10, 2023 Autolus Therapeutics Presents Clinical Data Updates at the American Society of Hematology (ASH) Annual Meeting 2023 December 10, 2023 Latest article Nvidia CEO aiming to set up base in Vietnam, Reuters reports December 10, 2023 Utz Brands to host investor day December 10, 2023 Updated Odronextamab Data from Relapsed/Refractory Diffuse Large B-cell Lymphoma Pivotal Trial Showed Deep and Durable Responses and the Potential of ctDNA To Predict Long-term... December 10, 2023 Jasper Therapeutics Presents Positive Final Results from Phase 1 Study of Briquilimab in Patients with AML or MDS Undergoing Hematopoietic Cell Transplant in Oral... December 10, 2023 Autolus Therapeutics presents clinical data updates at ASH Annual Meeting 2023 December 10, 2023